Read this manager's filing book
Disclosed positions
Forefront Analytics, LLC: source evidence dated 2026-08-14T03:59:59.999Z.
- Issuer
- VANGUARD INTL EQUITY INDEX F
- Ticker
- VWO
- Class
- FTSE EMR MKT ETF
- Reported value
- $10,766,629
- Reported amount
- 180,376
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0001085146-26-000598Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| VANGUARD INTL EQUITY INDEX F | VWO | FTSE EMR MKT ETF | $10,766,629 | 180,376 | SH | None |
| ISHARES TR | ESGD | ESG AW MSCI EAFE | $10,717,648 | 104,247 | SH | None |
| ISHARES INC | ESGE | ESG AWR MSCI EM | $10,522,268 | 192,398 | SH | None |
| ISHARES TR | HDV | CORE HIGH DV ETF | $9,394,930 | 342,756 | SH | None |
| ISHARES TR | MTUM | MSCI USA MMENTM | $8,376,602 | 24,434 | SH | None |
| NUSHARES ETF TR | NULV | NUVEEN ESG LRGVL | $7,044,168 | 140,912 | SH | None |
| DBX ETF TR | DBEF | XTRACK MSCI EAFE | $6,923,477 | 126,734 | SH | None |
| FLEXSHARES TR | ESGG | STOX GBL ESG SLT | $5,051,990 | 21,669 | SH | None |
| NVIDIA CORPORATION | NVDA | COM | $3,908,177 | 19,532 | SH | None |
| VANGUARD TAX-MANAGED FDS | VEA | VAN FTSE DEV MKT | $3,388,595 | 47,559 | SH | None |
| ISHARES TR | IVV | CORE S&P500 ETF | $3,332,842 | 4,450 | SH | None |
| ISHARES INC | HEEM | CUR HD MSCI EM | $2,603,409 | 58,203 | SH | None |
| JPMORGAN CHASE & CO | JPM | COM | $1,635,830 | 4,997 | SH | None |
| DEERE & CO | DE | COM | $743,196 | 1,172 | SH | None |
| UNITEDHEALTH GROUP INC | UNH | COM | $585,796 | 1,409 | SH | None |
| INCYTE CORP | INCY | COM | $577,116 | 5,091 | SH | None |
| EDWARDS LIFESCIENCES CORP | EW | COM | $557,053 | 6,158 | SH | None |
| PROSHARES TR | SSO | PSHS ULT S&P 500 | $551,159 | 8,180 | SH | None |
| PROSHARES TR | UWM | PSHS ULTRUSS2000 | $537,666 | 7,997 | SH | None |
| ABBOTT LABORATORIES | ABT | COM | $514,078 | 5,665 | SH | None |
| WISDOMTREE TR | EES | US SMALLCAP FUND | $475,886 | 7,020 | SH | None |
| PFIZER INC | PFE | COM | $438,489 | 18,210 | SH | None |
| MEDTRONIC PLC | MDT | SHS | $416,108 | 5,319 | SH | None |
| DANAHER CORP DEL | DHR | COM | $388,506 | 2,040 | SH | None |
| THERMO FISHER SCIENTIFIC INC | TMO | COM | $335,619 | 669 | SH | None |
| BLUE OWL TECHNOLOGY FIN CORP | OTF | COMMON STOCK | $306,919 | 29,654 | SH | None |
| LEGEND BIOTECH CORP | LEGN | SPONSORED ADS | $305,204 | 10,568 | SH | None |
| PHILIP MORRIS INTL INC | PM | COM | $264,600 | 1,463 | SH | None |
| REGENERON PHARMACEUTICALS | REGN | COM | $258,830 | 415 | SH | None |
| SCHWAB STRATEGIC TR | SCHD | US DIVIDEND EQ | $243,406 | 7,676 | SH | None |
| VANGUARD INDEX FDS | VTV | VALUE ETF | $236,319 | 1,084 | SH | None |
| ZURA BIO LTD | ZURA | CLASS A ORD SHS | $159,111 | 26,968 | SH | None |
| GERON CORP | GERN | COM | $113,637 | 88,779 | SH | None |
| CYTOMX THERAPEUTICS INC. | CTMX | COM | $93,874 | 25,033 | SH | None |
| BICYCLE THERAPEUTICS PLC | BCYC | SPONSORED ADS | $92,525 | 21,822 | SH | None |
| NKARTA INC | NKTX | COM | $81,943 | 28,955 | SH | None |
| ANNEXON INC | ANNX | COM | $81,310 | 14,240 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.